Correlation Engine 2.0
Clear Search sequence regions

Sizes of these terms reflect their relevance to your search.

Sirtuin 2 (SIRT2) is a member of the human sirtuins, which regulates various biological processes and is deemed as a novel biomarker for different cancers. Depending on the tumor type, SIRT2 knockout leads to a controversial role in tumorigenesis, however, pharmacological inhibition of SIRT2 results exclusively in growth inhibition of various cancer cells. In this respect, selective SIRT2 inhibitors hold therapeutic promise in a wide range of tumors. The literature has a batch of successful stories of SIRT2 modulators discovery. This review presents our perspective on the up-to-date selective SIRT2 inhibitors and their antiproliferative activity. Copyright © 2021 Elsevier Masson SAS. All rights reserved.


Eslam Roshdy, Muhamad Mustafa, Abd El-Rahman Shaltout, Mohamed O Radwan, Mahmoud A A Ibrahim, Mahmoud E Soliman, Mikako Fujita, Masami Otsuka, Taha F S Ali. Selective SIRT2 inhibitors as promising anticancer therapeutics: An update from 2016 to 2020. European journal of medicinal chemistry. 2021 Nov 15;224:113709

Expand section icon Mesh Tags

Expand section icon Substances

PMID: 34303869

View Full Text